Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinoma

BACKGROUND: Chemotherapy combined with immune checkpoints inhibitors (ICIs) has been established as a standard treatment for locally advanced, metastatic, or recurrent esophageal squamous cell cancer (ESCC). However, the optimal chemotherapy regimen in combination therapy is still unclear. PURPOSE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Ji, Yanyan, Shen, Lin, Yin, Xudong, Huang, Tianyu, Deng, Bin, Guo, Hong, Wu, Yunjiang, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808083/
https://www.ncbi.nlm.nih.gov/pubmed/36605427
http://dx.doi.org/10.3389/fonc.2022.1015302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808083/
https://www.ncbi.nlm.nih.gov/pubmed/36605427
http://dx.doi.org/10.3389/fonc.2022.1015302

Ejemplares similares